Skip to main content
Journal cover image

GRADE guidelines 6. Rating the quality of evidence--imprecision.

Publication ,  Journal Article
Guyatt, GH; Oxman, AD; Kunz, R; Brozek, J; Alonso-Coello, P; Rind, D; Devereaux, PJ; Montori, VM; Freyschuss, B; Vist, G; Jaeschke, R ...
Published in: J Clin Epidemiol
December 2011

GRADE suggests that examination of 95% confidence intervals (CIs) provides the optimal primary approach to decisions regarding imprecision. For practice guidelines, rating down the quality of evidence (i.e., confidence in estimates of effect) is required if clinical action would differ if the upper versus the lower boundary of the CI represented the truth. An exception to this rule occurs when an effect is large, and consideration of CIs alone suggests a robust effect, but the total sample size is not large and the number of events is small. Under these circumstances, one should consider rating down for imprecision. To inform this decision, one can calculate the number of patients required for an adequately powered individual trial (termed the "optimal information size" [OIS]). For continuous variables, we suggest a similar process, initially considering the upper and lower limits of the CI, and subsequently calculating an OIS. Systematic reviews require a somewhat different approach. If the 95% CI excludes a relative risk (RR) of 1.0, and the total number of events or patients exceeds the OIS criterion, precision is adequate. If the 95% CI includes appreciable benefit or harm (we suggest an RR of under 0.75 or over 1.25 as a rough guide) rating down for imprecision may be appropriate even if OIS criteria are met.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Clin Epidemiol

DOI

EISSN

1878-5921

Publication Date

December 2011

Volume

64

Issue

12

Start / End Page

1283 / 1293

Location

United States

Related Subject Headings

  • Sample Size
  • Risk
  • Randomized Controlled Trials as Topic
  • Practice Guidelines as Topic
  • Meta-Analysis as Topic
  • Humans
  • Evidence-Based Medicine
  • Epidemiology
  • Confidence Intervals
  • 4202 Epidemiology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Guyatt, G. H., Oxman, A. D., Kunz, R., Brozek, J., Alonso-Coello, P., Rind, D., … Schünemann, H. J. (2011). GRADE guidelines 6. Rating the quality of evidence--imprecision. J Clin Epidemiol, 64(12), 1283–1293. https://doi.org/10.1016/j.jclinepi.2011.01.012
Guyatt, Gordon H., Andrew D. Oxman, Regina Kunz, Jan Brozek, Pablo Alonso-Coello, David Rind, P. J. Devereaux, et al. “GRADE guidelines 6. Rating the quality of evidence--imprecision.J Clin Epidemiol 64, no. 12 (December 2011): 1283–93. https://doi.org/10.1016/j.jclinepi.2011.01.012.
Guyatt GH, Oxman AD, Kunz R, Brozek J, Alonso-Coello P, Rind D, et al. GRADE guidelines 6. Rating the quality of evidence--imprecision. J Clin Epidemiol. 2011 Dec;64(12):1283–93.
Guyatt, Gordon H., et al. “GRADE guidelines 6. Rating the quality of evidence--imprecision.J Clin Epidemiol, vol. 64, no. 12, Dec. 2011, pp. 1283–93. Pubmed, doi:10.1016/j.jclinepi.2011.01.012.
Guyatt GH, Oxman AD, Kunz R, Brozek J, Alonso-Coello P, Rind D, Devereaux PJ, Montori VM, Freyschuss B, Vist G, Jaeschke R, Williams JW, Murad MH, Sinclair D, Falck-Ytter Y, Meerpohl J, Whittington C, Thorlund K, Andrews J, Schünemann HJ. GRADE guidelines 6. Rating the quality of evidence--imprecision. J Clin Epidemiol. 2011 Dec;64(12):1283–1293.
Journal cover image

Published In

J Clin Epidemiol

DOI

EISSN

1878-5921

Publication Date

December 2011

Volume

64

Issue

12

Start / End Page

1283 / 1293

Location

United States

Related Subject Headings

  • Sample Size
  • Risk
  • Randomized Controlled Trials as Topic
  • Practice Guidelines as Topic
  • Meta-Analysis as Topic
  • Humans
  • Evidence-Based Medicine
  • Epidemiology
  • Confidence Intervals
  • 4202 Epidemiology